This inventor holds 1 USPTO granted patent. Top assignee: The Wistar Institute. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982
Title: Kenneth F. Mitchell: Innovator in Antibody Development
Introduction
Kenneth F. Mitchell is a notable inventor based in Unionville, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. His work has implications for cancer diagnostics and treatment.
Latest Patents
Kenneth F. Mitchell holds a patent for a monoclonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen. This invention is particularly important as it identifies a unique antigen site on the 180,000 dalton molecular weight carcinoembryonic antigen, which is not shared by other molecular weight carcinoembryonic antigens released by colorectal carcinoma. This specificity can enhance the accuracy of cancer detection and treatment.
Career Highlights
Mitchell is affiliated with The Wistar Institute, a prominent research institution known for its focus on cancer and infectious diseases. His work at this institute has allowed him to contribute to groundbreaking research in immunology and oncology.
Collaborations
Throughout his career, Kenneth F. Mitchell has collaborated with esteemed colleagues, including Hilary Koprowski and Zenon Steplewski. These collaborations have furthered the development of innovative solutions in the field of antibody research.
Conclusion
Kenneth F. Mitchell's contributions to the field of monoclonal antibodies exemplify the impact of innovative research on cancer diagnostics. His patent and work at The Wistar Institute highlight the importance of targeted therapies in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile